R&D
Research & Development
Research and Development of Quasi-Drugs and Medical Devices

Through the research and development of medical polymers and patent-based manufacturing, we supply our products to hospitals and clinics through trusted distributors.
Based on our existing raw materials, we have developed a new composition, filed a patent application, and completed the registration and approval of a Class II wound care product. Moving forward, we plan to actively pursue the development of Class III and IV polymer-based biomaterials, biological tissues, and bioavailable materials.
-
Research & Development
Establishing a Corporate Research Institute to Advance R&D
-
Product Test Registration
Completed in-house production evaluation for the development of Class II products.
-
Approval
Established a quality management system for medical device manufacturing.
R&D
Driven by a rigorous spirit of experimentation and passionate dedication,
we give our best to research every step of the way.

DASON’s Corporate Research Institute was established in 2024 and continues to expand its product portfolio and technological capabilities through the research and development of medical products and patent applications for advanced materials.
